InvestorsHub Logo
Followers 3
Posts 107
Boards Moderated 0
Alias Born 07/02/2013

Re: None

Thursday, 09/19/2013 11:04:08 PM

Thursday, September 19, 2013 11:04:08 PM

Post# of 130505
More indications: Hepatic encephalopathy; Hyperammonemia
we all know about: PD, Alzheimer’s disease (AD), and ischemia.

Role of Astrocytes in Brain Function and Disease

Marta Sidoryk-Wegrzynowicz1
Michal Wegrzynowicz2,3
Eunsook Lee4
Aaron B. Bowman2,3
Michael Aschner1,3,4

1Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232
2Department of Neurology, Vanderbilt University Medical Center, Nashville, TN 37232
3Kennedy Center for Research on Human Development, Vanderbilt University Medical Center, Nashville, TN 37232
4Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232

Michael Aschner, PhD, Department of Pediatrics, 2215-B Garland Avenue 11415 MRB IV, Vanderbilt University Medical Center, Nashville, TN 37232-0414, USA; phone: 615-322-8024; fax: 615-936-4080; e-mail: michael.aschner@vanderbilt.edu

Abstract

Astrocytes assume multiple roles in maintaining an optimally suited milieu for neuronal function. Select astrocytic functions include the maintenance of redox potential, the production of trophic factors, the regulation of neurotransmitter and ion concentrations, and the removal of toxins and debris from the cerebrospinal fluid (CSF). Impairments in these and other functions, as well as physiological reactions of astrocytes to injury, can trigger or exacerbate neuronal dysfunction. This review addresses select metabolic interactions between neurons and astrocytes and emphasizes the role of astrocytes in mediating and amplifying the progression of several neurodegenerative disorders, such as Parkinson’s disease (PD), hepatic encephalopathy (HE), hyperammonemia (HA), Alzheimer’s disease (AD), and ischemia.